CGrowth Capital, Inc. - CGRA

CGRA Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
CGRA	-19.0	-5.6	25.9	70	-1.2	-24.4	-74.4	-15	240	-96.6
S&P 500	1.0	0.6	1.1	2.4	8.9	23.6	36.4	80.6	195.1	33856.2

Compare CGRA with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	CGRA
name	CGrowth Capital, Inc.
price	0.0034
changes percentage	-19.0476
change	-0.0008
day low	0.0034
day high	0.0039
year high	0.008
year low	0.001
market cap	2074255
price avg 50	0.0029
price avg 200	0.00282
exchange	PNK
volume	398987
avg volume	2258952
open	0.0038
previous close	0.0042
eps	0.01
pe	0.34
earnings announcement	2025-03-26T10:00:00.000+0000
shares outstanding	610075000
timestamp	2025-01-17 20:31:18

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 54.3%

Overall Quarterly Financial Health: 64.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
revenue	1065843	1099022	-3.02
gross profit	422696	450235	-6.12
gross profit ratio	0.4	0.41	-3.19
research and development expenses	1544	0	NaN
operating expenses	148427	268894	-44.80
interest income	0	0	NaN
interest expense	14930	14395	3.72
ebitda	274270	179541	52.76
ebitdaratio	0.26	0.17	55.95
operating income	274269	181340	51.25
operating income ratio	0.26	0.17	55.95
net income	259339	165146	57.04
net income ratio	0.24	0.15	61.92
eps	0.0	0.0	66.67

Overall Score of Annual Income Statement

0.71 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 1 million in 2023 from 1 million in 2022 representing a change of -3.02%. This indicates a sales shrinking, which is a negative sign for the company.

  Gross Profit: Gross Profit decreased to 0 million in 2023 from 0 million in 2022 representing a change of -6.12%. This indicates a sales profitability decline, which is a negative sign for the company.

• 📈 Positive Indicators

  Research and Development (R&D) Expenses: R&D Expenses increased to 0 million in 2023 from 0 million in 2022 representing a change of nan%. This shows that the company continues to invest in innovation and product development, which is crucial for long-term growth.

  Operating Expenses: Operating Expenses decreased to 0 million in 2023 from 0 million in 2022 representing a change of -44.8%. The decrease in operating expenses can be attributed to various factors such as improved profitability, cost optimization and financial stability, lower operating expenses can be positive indicators.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 0 million in 2023 from 0 million in 2022 representing a change of 52.76%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 0 million in 2023 from 0 million in 2022 representing a change of 51.25%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 0 million in 2023 from 0 million in 2022 representing a change of 57.04%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0000000000
revenue	285628	282799	1.00
gross profit	74545	172507	-56.79
gross profit ratio	0.26	0.61	-57.22
research and development expenses	0	0	NaN
operating expenses	16641	129367	-87.14
interest income	0	0	NaN
interest expense	0	997	-100.00
ebitda	57900	43140	34.21
ebitdaratio	0.2	0.15	32.88
operating income	57904	43140	34.22
operating income ratio	0.2	0.15	32.89
net income	56839	42143	34.87
net income ratio	0.2	0.15	33.54
eps	0.0	0.0	0.00

Overall Score of Quarterly Income Statement

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Revenue Growth: revenue increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 1.0%. This indicates a sales growth, which is a positive sign for the company.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 34.21%. The increase in EBITDA indicates improved operational efficiency and profitability.

  Operating Income: Operating income increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 34.22%. The increase in operating income indicates better operational performance and increased profitability.

  Net Income: Net income increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 34.87%. The increase in net income shows improved profitability and indicates that the company is generating more profit for each dollar of revenue.

• 📉 Negative Indicators

  Gross Profit: Gross Profit decreased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of -56.79%. This indicates a sales profitability decline, which is a negative sign for the company.

  Operating Expenses: Operating Expenses increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of -87.14%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
total assets	3066823	2099676	46.06
total liabilities	1274294	797701	59.75
total equity	1792529	1301975	37.68
cash and cash equivalents	386158	281375	37.24
short term investments	0	0	NaN
long term investments	1089889	1023674	6.47
total current assets	1825934	1076002	69.70
total non current assets	1240889	1023674	21.22
total current liabilities	734524	267931	174.15
total non current liabilities	539770	529770	1.89
common stock	565818	493603	14.63
retained earnings	1055116	636496	65.77
total debt	539770	529770	1.89

Overall Score of Annual Balance Sheet

0.67 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3 million in 2023 from 2 million in 2022 representing a change of 46.06%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 2 million in 2023 from 1 million in 2022 representing a change of 37.68%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 0 million in 2023 from 0 million in 2022 representing a change of 37.24%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 2 million in 2023 from 1 million in 2022 representing a change of 69.7%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2023 from 0 in 2022 representing a change of 14.63%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 1 million in 2023 from 1 million in 2022 representing a change of 65.77%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1 million in 2023 from 1 million in 2022 representing a change of 59.75%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 1 million in 2023 from 0 million in 2022 representing a change of 174.15%. This indicates a higher short-term debt burden.

  Total Debt: Total Debt increased to 1 million in 2023 from 1 million in 2022 representing a change of 1.89%. This indicates an increase in overall debt burden.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0000000000
total assets	3066823	2983803	2.78
total liabilities	1274294	1248112	2.10
total equity	1792529	1735691	3.27
cash and cash equivalents	386158	357084	8.14
short term investments	0	0	NaN
long term investments	1089889	1089889	0.00
total current assets	1825934	1742914	4.76
total non current assets	1240889	1240889	0.00
total current liabilities	734524	708342	3.70
total non current liabilities	539770	539770	0.00
common stock	565818	524818	7.81
retained earnings	1055116	998278	5.69
total debt	539770	539770	0.00

Overall Score of Quarterly Balance Sheet

0.75 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Total Assets: Total Assets increased to 3 million in 2023Q4 from 3 million in 2023Q3 representing a change of 2.78%. Suggesting a growth in asset holdings.

  Total Equity: Total Equity increased to 2 million in 2023Q4 from 2 million in 2023Q3 representing a change of 3.27%. This indicates an increase in shareholders' equity.

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 8.14%. This indicates an increase in available liquid assets.

  Total Current Assets: Total Current Assets increased to 2 million in 2023Q4 from 2 million in 2023Q3 representing a change of 4.76%. This indicates a better liquidity position.

  Common Stock: Common Stock increased to 1 in 2023Q4 from 1 in 2023Q3 representing a change of 7.81%. This indicates an increase in ownership interest.

  Retained Earnings: Retained Earnings increased to 1 million in 2023Q4 from 1 million in 2023Q3 representing a change of 5.69%. This indicates an accumulated profits.

• 📉 Negative Indicators

  Total Liabilities: Total Liabilities increased to 1 million in 2023Q4 from 1 million in 2023Q3 representing a change of 2.1%. This indicates an increase in overall liabilities.

  Total Current Liabilities: Total Current Liabilities increased to 1 million in 2023Q4 from 1 million in 2023Q3 representing a change of 3.7%. This indicates a higher short-term debt burden.

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0000000000
net change in cash	104783	273191	-61.64
operating cash flow	80783	3710264	-97.82
free cash flow	-70217	-10948566	99.36
capital expenditure	-151000	-14658830	98.97
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	14689652	-100.00
investments in property plant and equipment	-151000	-14658830	98.97
net cash used for investing activites	-217215	3761287	-105.78
debt repayment	454.0	0	NaN
common stock issued	231215	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	231669	-4159849	105.57
cash at end of period	386158	281375	37.24
accounts receivables	0	0	NaN
cash at beginning of period	281375	8184	3338.11

Overall Score of Annual Cashflow Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2023 from 0 million in 2022 representing a change of -61.64%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow decreased to 0 million in 2023 from 4 million in 2022 representing a change of -97.82%. This indicates that the company generated less cash from its core business operations.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2023 from -15 million in 2022 representing a change of 98.97%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• 📈 Positive Indicators

  Free Cash Flow: Free Cash Flow increased to 0 million in 2023 from -11 million in 2022 representing a change of 99.36%. This indicates an increase in cash generated after accounting for capital expenditures.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023Q4	2023Q3	Q/Q change %
0000000000
operating cash flow	129074	22161	482.44
free cash flow	229070	-77839	394.29
capital expenditure	99996	-100000	200.00
depreciation and amortization	0	0	NaN
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	0	0	NaN
accounts payables	0	0	NaN
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	99996	-100000	200.00
net cash used for investing activites	0	-125000	100.00
debt repayment	0	160000	-100.00
common stock issued	0	1000	-100.00
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-109546	161000	-168.04
net change in cash	29074	58161	-50.01
cash at end of period	386158	357084	8.14
cash at beginning of period	357084	298923	19.46

Overall Score of Quarterly Cashflow Statement

0.5 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of -50.01%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 200.0%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 482.44%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 0 million in 2023Q4 from 0 million in 2023Q3 representing a change of 394.29%. This indicates an increase in cash generated after accounting for capital expenditures.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.0	0.0	-8.26
net income per share	0.0	0.0	48.55
operating cash flow per share	0.0	0.01	-97.94
free cash flow per share	-0.0	-0.02	99.39
cash per share	0.0	0.0	29.82
book value per share	0.0	0.0	30.24
tangible book value per share	0.0	0.0	22.97
shareholders equity per share	0.0	0.0	30.24
interest debt per share	0.0	0.0	-3.57
market cap	2702039.83	12681940.98	-78.69
enterprise value	2855651.83	12930335.98	-77.92
pe ratio	10.42	76.79	-86.43
price to sales ratio	2.54	11.54	-78.03
pocfratio	33.45	3.42	878.57
pfcf ratio	-38.48	-1.16	-3222.16
pb ratio	1.51	9.74	-84.52
ptb ratio	1.51	9.74	-84.52
ev to sales	2.68	11.77	-77.23
enterprise value over ebitda	10.41	72.02	-85.54
ev to operating cash flow	35.35	3.49	914.33
ev to free cash flow	-40.67	-1.18	-3343.58
earnings yield	0.1	0.01	637.04
free cash flow yield	-0.03	-0.86	96.99
debt to equity	0.3	0.41	-26.00
debt to assets	0.18	0.25	-30.24
net debt to ebitda	0.56	1.38	-59.52
current ratio	2.49	4.02	-38.10
interest coverage	18.37	12.6	45.83
income quality	0.31	22.47	-98.61
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.0	0	NaN
intangibles to total assets	0.03	0	NaN
capex to operating cash flow	1.87	3.95	-52.69
capex to revenue	0.14	13.34	-98.94
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.01	0.0	39.09
roic	0.19	0.24	-17.90
return on tangible assets	0.09	0.08	11.14
graham net net	0.0	-0.0	207.37
working capital	1091410	808071	35.06
tangible asset value	1692529	1301975	30.00
net current asset value	551640	278301	98.22
invested capital	1242410	808071	53.75
average receivables	618833	2287622.5	-72.95
average payables	501227.5	1173293	-57.28
average inventory	480168.5	207633	131.26
days sales outstanding	296.27	123.72	139.47
days payables outstanding	416.86	150.73	176.55
days of inventory on hand	309.34	233.62	32.41
receivables turnover	1.23	2.95	-58.24
payables turnover	0.88	2.42	-63.84
inventory turnover	1.18	1.56	-24.48
roe	0.14	0.13	14.06
capex per share	0.0	0.03	-99.03

• ROE:

• Negative

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 10.42 on 2023-12-31 from 76.79 on 2022-12-31, representing a change of -86.43%. Indicating a decrease in the relative valuation of the company's stock.

• Neutral

  Current Ratio: Current Ratio decreased to 2.49 on 2023-12-31 from 4.02 on 2022-12-31, representing a change of -38.10%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. However, it is still above 1, indicating the ability to cover short-term obligations.

• Positive

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.30 on 2023-12-31 from 0.41 on 2022-12-31, representing a change of -26.00%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Quarterly Financial Ratios

	2023-12-31 Q4	2023-09-30 Q3	Q/Q change %
CGRA
calendar year	2023	2023	NaN
revenue per share	0.0	0.0	-0.88
net income per share	0.0	0.0	32.36
operating cash flow per share	0.0	0.0	471.60
free cash flow per share	0.0	-0.0	388.81
cash per share	0.0	0.0	6.13
book value per share	0.0	0.0	1.35
tangible book value per share	0.0	0.0	-4.30
shareholders equity per share	0.0	0.0	1.35
interest debt per share	0.0	0.0	-2.04
market cap	2774543.92	3665493.26	-24.31
enterprise value	2928155.92	3848179.26	-23.91
pe ratio	12.2	21.74	-43.88
price to sales ratio	9.71	12.96	-25.06
pocfratio	21.5	165.4	-87.00
pfcf ratio	12.11	-47.09	125.72
pb ratio	1.55	2.11	-26.71
ptb ratio	1.55	2.11	-26.71
ev to sales	10.25	13.61	-24.66
enterprise value over ebitda	50.57	89.2	-43.31
ev to operating cash flow	22.69	173.65	-86.94
ev to free cash flow	12.78	-49.44	125.86
earnings yield	0.02	0.01	78.18
free cash flow yield	0.08	-0.02	488.79
debt to equity	0.3	0.31	-3.17
debt to assets	0.18	0.18	-2.71
net debt to ebitda	2.65	4.23	-37.35
current ratio	2.49	2.46	1.03
interest coverage	0	43.27	-100.00
income quality	2.27	0.53	331.85
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0	0	NaN
intangibles to total assets	0.03	0	NaN
capex to operating cash flow	0.77	4.51	-82.83
capex to revenue	0.35	0.35	-0.99
capex to depreciation	0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.0	0.0	15.83
roic	0.04	0.0	3721.91
return on tangible assets	0.02	0.01	35.64
graham net net	0.0	0.0	82.12
working capital	1091410	1034572	5.49
tangible asset value	1692529	1735691	-2.49
net current asset value	551640	494802	11.49
invested capital	1242410	1085572	14.45
average receivables	895473	842604.5	6.27
average payables	721433	585632.5	23.19
average inventory	487130	429189	13.50
days sales outstanding	272.6	294.63	-7.48
days payables outstanding	313.18	578.02	-45.82
days of inventory on hand	232.4	350.22	-33.64
receivables turnover	0.33	0.31	8.08
payables turnover	0.29	0.16	84.56
inventory turnover	0.39	0.26	50.70
roe	0.03	0.02	30.60
capex per share	0.0	0.0	-1.86

• Negative

  ROE: Return on Equity (ROE) increased to 0.03 on 2023-12-31 Q4 from 0.02 on 2023-09-30 Q3, representing a change of 30.60%. However, ROE is <= 5%, suggesting that the company has not been generating high returns for its shareholders.

  PE Ratio: Price-to-Earnings (P/E) Ratio decreased to 12.20 on 2023-12-31 Q4 from 21.74 on 2023-09-30 Q3, representing a change of -43.88%. Indicating a decrease in the relative valuation of the company's stock.

• Positive

  Current Ratio: Current Ratio increased to 2.49 on 2023-12-31 Q4 from 2.46 on 2023-09-30 Q3, representing a change of 1.03%. The current ratio has been increasing, suggesting an increase in the company's short-term liquidity. Also, it's above 1, indicating the ability to cover short-term obligations.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio decreased to 0.30 on 2023-12-31 Q4 from 0.31 on 2023-09-30 Q3, representing a change of -3.17%. The debt-to-equity ratio has been decreasing, indicating that the company has been relying less on debt financing. A ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None